Journal article
Fluvoxamine in the treatment of major depressive disorder: an open multicentric study
Abstract
OBJECTIVE: This research studied the efficacy and tolerability of fluvoxamine in the treatment of major depressive disorder (MDD), during 6 weeks, in an open trial, without placebo or active comparator. A secondary objective was the evaluation of the effects of fluvoxamine on the sleep of the pacients. METHODS: 104 patients were inicially included, with the diagnosis of MDD in accordance to the criteria of the Diagnostic and Statistical Manual …
Authors
Del Porto JA; de Mello AF; Kerr-Correa F; dos Santos A; Moreno RA; dos Santos CHR; Chaves AV; Versiani M; Nardi AE; de Oliveira IR
Journal
Jornal Brasileiro de Psiquiatria, Vol. 56, No. 1, pp. 17–22
Publisher
FapUNIFESP (SciELO)
Publication Date
2007
DOI
10.1590/s0047-20852007000100006
ISSN
0047-2085